When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Artrite reativa

最后审阅: 23 Sep 2025
最后更新: 04 Feb 2022

小结

定义

病史和体格检查

关键诊断因素

  • presença de fatores de risco
  • artrite periférica
  • artrite axial
完整详情

其他诊断因素

  • sintomas constitucionais
  • entesite
  • comprometimento da membrana mucosa
  • erupção cutânea
  • balanite circinada
  • manifestações oculares
  • manifestações cardíacas
完整详情

危险因素

  • sexo masculino
  • genótipo HLA-B27
  • infecção gastrointestinal ou por clamídias anterior
  • imunoterapia com BCG
完整详情

诊断性检查

首要检查

  • velocidade de hemossedimentação (VHS)
  • proteína C-reativa
  • FAN
  • fator reumatoide
  • coproculturas e culturas de material urogenital
  • radiografias simples
  • artrocentese com análise do líquido sinovial
完整详情

需考虑的检查

  • HLA (antígeno leucocitário) B27
  • testes de amplificação de ácido nucleico
  • RNM
  • ultrassonografia
完整详情

治疗流程

急症处理

alívio sintomático

持续性治疗

artrite reativa persistente ou crônica

撰稿人

作者

John D. Carter, MD

Professor of Medicine

Division of Rheumatology

Chief

University of South Florida College of Medicine

Tampa

FL

利益声明

JDC is on the speakers bureau for Abbvie and Amgen. JDC is a co-author of several references cited in this topic.

鸣谢

Dr John D. Carter would like to gratefully acknowledge Dr Jason P. Guthrie, a previous contributor to this topic. JPG declares that he has no competing interests.

同行评议者

J.S.H. Gaston, MA, PhD, BM, BCh, FRCP, FMedSci

Professor of Rheumatology

University of Cambridge

Cambridge

UK

利益声明

JSHG declares that he has no competing interests.

Luis R. Espinoza, MD

Professor and Chief

Section of Rheumatology

Department of Internal Medicine

LSU Health Sciences Center

New Orleans

LA

Disclosures

LRE is a co-author of several references cited in this topic. Unfortunately, we have since been made aware that Dr Luis R. Espinoza is deceased.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Parker CT, Thomas D. Reiter's syndrome and reactive arthritis. J Am Osteopath Assoc. 2000;100:101-104. Abstract

Dougados M, van der Linden S, Juhlin R, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991;34:1218-1227. Abstract

Toivanen A. Managing reactive arthritis. Rheumatology (Oxford). 2000;39:117-119. Abstract

Carter JD, Espinoza LR, Inman RD, et al. Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial. Arthritis Rheum. 2010;62:1298-1307. Abstract

Colmegna I, Espinoza LR. Recent advances in reactive arthritis. Curr Rheumatol Rep. 2005;7:201-207. Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Artrite reativa images
  • Differentials

    • Espondilite anquilosante (EA)
    • Artrite psoriática
    • Artrite reumatoide (AR)
    More Differentials
  • Guidelines

    • British Association of Sexual Health and HIV national guideline on the management of sexually acquired reactive arthritis 2021
    • ACR appropriateness criteria: chronic extremity joint pain - suspected inflammatory arthritis
    More Guidelines
  • Patient information

    Clamídia

    Doença de Lyme

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer